Cancer Scenario

Growth biomarkers can be DNA, mRNA, proteins, metabolites, or procedures, for example, apoptosis, angiogenesis or expansion. The markers are created either by the tumor itself or by different tissues, in light of the nearness of disease or other related conditions, for example, irritation. Such biomarkers can be found in an assortment of liquids, tissues and cell lines. Biomarkers that Support a Treatment's Cellular or Molecular Action and furthermore they can Detect and Measure to Develop a Personalized Anticancer Treatment Plan.

 

  • Biomarkers, vaccines and pathology
  • Pharmacodynamics & pharmacokinetics
  • Cancer polymeric nanotechnology & drug design
  • Adverse effects of chemotherapy
  • Prognosis of cancer
  • Environmental carcinogenesis
  • Oncology case reports

Related Conference of Cancer Scenario

December 07-08, 2020

2nd Asia Pacific Oncology and Cancer Conference

Tokyo, Japan
December 10-11, 2020

4th Annual Conference on Skin Cancer and Dermatology

Abu Dhabi, UAE
February 25-26, 2021

5th Global summit on Cancer Science and Oncology

Vienna, Austria
April 05-06, 2021

2 nd Global Summit on Oncology and Hematology

Berlin, Germany
April 28-29, 2021

11th World Congress on Breast Cancer

Barcelona, Spain
May 17-18, 2021

8th World Congress on Epigenetics and Chromosome

Zurich, Switzerland
May 17-18, 2021

11th World Congress on Breast Cancer & Therapies

Prague, Czech Republic
June 23-24, 2021

41st Euro Congress on Cancer Science & Therapy

Barcelona, Spain
July 12-13, 2021

World Congress on Women Oncology & Care

Melbourne, Australia
July 12-13, 2021

Global Immuno-Oncology & Biomarkers Summit

Melbourne, Australia
August 13-14, 2021

2nd World Cancer, Oncology and Therapeutics Congress

Munich, Germany

Cancer Scenario Conference Speakers

Recommended Sessions

Related Journals

Are you interested in